 Multicenter trial L-carnitine maintenance hemodialysis patients II Clinical biochemical effects carnitine deficiency patients undergoing maintenance hemodialysis effects intravenous infusion L-carnitine placebo end dialysis treatment trial months month baseline months treatment double blind placebo Eighty-two long-term hemodialysis patients carnitine placebo study group clinical biochemical parameters treatment baseline values Intra-dialytic hypotension muscle cramps carnitine group improvement post-dialysis asthenia carnitine placebo groups Maximal oxygen consumption progressive work exercise test carnitine group ml/min unchanged placebo group L-carnitine treatment significant drop pre-dialysis concentrations serum urea nitrogen creatinine phosphorus SEM mg/dl significant changes variables placebo group Mid-arm circumference triceps skinfold thickness carnitine placebo patients mid-arm muscle area carnitine patients unchanged placebo patients